The Medical Affairs Professional Society is honored to announce the appointment of Charlotte Kremer, MD, MBA as the organization’s Chief Medical Officer. Kremer has previously served as Chair of the MAPS Board of Directors and as Chief Strategy Officer. As a result of becoming a part-time MAPS staff member, Charlotte will be relinquishing her Board position effective January 31, 2023. As a member of the Executive Leadership Team, Kremer will work closely with the CEO, the Professional Development Committee (PDC), Senior Advisor for Professional Development, the MAPS Learning & Development (L & D) Team, and the many committed MAPS volunteers to support the development and assessment of MAPS’ core offerings, including eLearning courses, certificate programs, MasterClass training programs, company-specific trainings, standards & guidance documents, white papers and other offerings. Additionally, Kremer will maintain her excellent external network with Medical Affairs executive peers to ensure MAPS resources and events effectively represent leadership perspectives.
Kremer brings over 25 years of experience in pharma; she recently retired from 10 years with Astellas where she held the position of Executive VP and Head of Medical Affairs. In this role, Dr. Kremer provided leadership for the Medical Affairs organization globally, an organization of approximately 1,000 Medical Affairs professionals. Prior to Astellas, she held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical programs in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility in Medical Affairs at Organon Pharmaceuticals, both in the Netherlands and in the United States. A native of the Netherlands, Dr. Kremer received her medical degree from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University’s Leonard N. Stern School of Business.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world, with MAPS speaking as the voice of the profession across organizations,” Kremer says. “I have helped guide MAPS as a volunteer since shortly after its founding and am overjoyed to be assuming the role of CMO at a time when we have the opportunity to provide knowledge and tools to help Medical Affairs professionals dramatically expand the competencies needed to capture the evolving scope of the Medical Affairs role.”
MAPS was founded in 2016 by industry leaders who recognized the need for a society to guide the profession and volunteered their time and expertise to create an organization that could represent Medical Affairs, globally. Today, MAPS is the premier non-profit global Medical Affairs organization with 11,000+ members across all levels of experience and Medical Affairs specialties, from 300+ companies, worldwide. The mission of MAPS is to help Medical Affairs be a strategic leader, identifying and addressing unmet patient, payer and policymaker and provider needs that advance clinical practice and improve patient outcomes.
“Having worked with Charlotte in her previous roles with MAPS, I know the value this collaboration is going to bring to the organization and to the Medical Affairs profession as a whole,” says Travis Hege, MAPS CEO. “I’m incredibly excited to continue working with Charlotte in this new capacity.”